Stocks · Technology · Services-Prepackaged Software

BiomX Inc.

PHGE Clue Score33
United States Fiscal year ends December CIK 0001739174 Results filed 12 Nov 2025

What the insiders did Net buying

By person

18 insiders · 104 transactions
1.3×

Jonathan Solomon holds only 1.3 times base salary in stock. $633.74K of shares against $453.32K in salary for 2025.

Salary from the company's own proxy. The shares are what Jonathan Solomon last reported holding, valued at $5.00, the price Common Stock, $0.0001 par value per share was last bought or sold at on the open market here, on 17 Mar 2026.

Insider
Role
Bought
Sold
Net
Holding
Worth
Change
Reuven Yeganeh
Director
—
$8.25M (4) scheduled
−$8.25M
0
$0.00
—
Chidozie Ugwumba
Exit Form 4 - former 10% owner
—
$318.09K (62)
−$318.09K
2,997,025
$14.99M
−17.6%
OrbiMed Israel BioFund GP Limited Partnership entity
10% owner
$284.44K (9)
$9.28K (1) scheduled
+$275.16K
16,587,142
$82.94M
+156.8%
Erez Chimovits
Director
$199.18K (7)
—
+$199.18K
4,626,978
$23.13M
+0.5%
Jonathan Eitan Solomon
Chief Executive Officer
$100.00K (1)
—
+$100.00K
126,748
$633.74K
—
Paul J Sekhri
Director
$50.00K (1)
—
+$50.00K
12,500
$62.50K
—
Lynne Marie Sullivan
Director
$50.00K (1)
—
+$50.00K
12,500
$62.50K
—
Jonas Grossman
Director
$49.24K (4)
—
+$49.24K
2,079,717
$10.40M
−39.1%
Alan Charles Moses
Director
$20.00K (1)
—
+$20.00K
5,000
$25.00K
—
Russell Greig
Director
$15.00K (1)
—
+$15.00K
3,750
$18.75K
—
Marina Wolfson
Chief Financial Officer
$15.00K (1)
—
+$15.00K
68,545
$342.73K
—
Assaf Oron
Chief Business Officer
$3.03K (3)
$4.07K (3)
−$1.04K
25,804
$129.02K
—
Gbolahan Amusa
Director
— (1)
—
$0.00
262,871
$1.31M
—
Cystic Fibrosis Foundation entity
10% owner
—
—
—
9,330,580
$46.65M
+105.0%
James E Flynn
Director
—
—
—
1,247,054
$6.24M
—
Kerry Propper
10% owner
—
—
—
260,771
$1.30M
—
Merav Bassan
Chief Development Officer
—
—
—
79,597
$397.99K
—
Thomas Layton Walton
10% owner
—
—
—
0
$0.00
−100.0%

No percentages here. This company's share count has moved by a factor of 2.9 over the window, from 10,111,516 to 29,006,165 shares. A split, a merger or a large issue changes what the company is, and a holding measured at one point in that run is not a fraction of it at another.